Your email has been successfully added to our mailing list.

×
0 0.00302114803625385 0.0161933534743203 0.0211480362537765 0.116525679758308 0.0392749244712991 -0.0120845921450151 -0.0262839879154078
Stock impact report

Atyr Pharma on go with study of lead drug in COVID-19; shares up 19% premarket [Seeking Alpha]

aTyr Pharma, Inc. (LIFE) 
Last atyr pharma, inc. earnings: 3/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: atyrpharma.com/investors-media
Company Research Source: Seeking Alpha
Thinly traded nano cap aTyr Pharma (NASDAQ:LIFE19%sign-offATYR1923 is a fusion protein designed to downregulate T cell responses thereby dampening inflammatory cytokine (protein) and chemokine signaling associated with severe COVID-19 cases. The company says it has also shown to improve lung function, in addition to reducing inflammation and fibrosis, in animal models of immune-mediated acute lung injury. Show less Read more
Impact Snapshot
Event Time:
LIFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for LIFE alerts
Opt-in for
LIFE alerts

from News Quantified
Opt-in for
LIFE alerts

from News Quantified